Morgan Stanley analyst Sarah Simon lowered the firm’s price target on AB InBev (BUD) to $63 from $68.50 and keeps an Overweight rating on the shares. The firm is updating estimates to reflect the latest scanner data in European and U.S. markets, as well as latest foreign exchange rates, which it says “have both a translational and transactional impact on profitability.” While the firm still sees AB InBev offering “very attractive” cash returns, growth and share price performance is likely to be second half weighted and it sees better near-term opportunities elsewhere in Beverages, so the stock was also removed as the analyst’s “Top Pick” in the space.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BUD:
- AB InBev price target lowered to EUR 66 from EUR 70 at UBS
- Why Investors Should Buy Diageo Stock (DEO) on the Dip
- AB InBev price target lowered to $55 from $65 at TD Cowen
- Drink makers drop as Surgeon General proposes cancer warning on alcohol
- Surgeon General issues new advisory on link between alcohol and cancer risk